Predictive value of xrcc1 gene polymorphisms for side effects in patients undergoing whole breast radiotherapy: A meta-analysis

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 12, 2012, Pages 6121-6128

  Xie, Xiao Xue ^a   Ouyang, Shu Yu ^a   Jin, He Kun ^a   Wang, Hui ^a   Zhou, Ju Mei ^a   Hu, Bing Qiang ^a  

^a Central South University   (China)

Author keywords

Meta analysis; Side effect; Single nucleotide polymorphisms; Whole breast radiotherapy; XRCC1

Indexed keywords

ALLELE; CASE CONTROL STUDY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE; HUMAN; META ANALYSIS; RISK FACTOR;

ALLELES; CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 84877026874     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.12.6121     Document Type: Article

References (44)

1. Ades AE, Lu G, Higgins JP (2005). The interpretation of random-effects meta-analysis in decision model. Med Decis Making, 25, 646-54.
2. Ambrosone CB, Sweeney C, Coles BF, et al (2001). Polymorphisms in glutathione S-transferases (GSTM1 and GSTT1) and survival after treatment for breast cancer. Cancer Res, 61, 7130-5.
3. Andreassen CN, Alsner J, Overgaard M, Overgaard J (2003). Prediction of normal tissue radiosensitivity from polymorphisms in candidate gene. Radiother Oncol, 69, 127-35.
4. Andreassen CN, Alsner J, Overgaard M, Sørensen FB, Overgaard J (2006). Risk of radiation-induced subcutaneous fibrosis in relation to single nucleotide polymorphisms in TGFB1, SOD2, XRCC1, XRCC3, APEX and ATM--a study based on DNA from formalin fixed paraffin embedded tissue samples. Int J Radiat Biol, 82, 577-86.
5. Attia J, Thakkinstian A, D'Este C (2003). Meta-analyses of molecular association studies: methodologic lessons for genetic epidemiology. J Clin Epidemiol, 56, 297-303.
6. Boyle P, Ferlay J (2005). Cancer incidence and mortality in Europe, 2004. Ann Oncol, 16, 481-8.
7. Bray F, McCarron P, Parkin DM (2004). The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res, 6, 229-39.
8. Brem R, Cox DG, Chapot B, et al (2006). The XRCC1-77T->C variant: haplotypes, breast cancer risk, response to radiotherapy and the cellular response to DNA damage. Carcinogenesis, 27, 2469-74.
9. Burri RJ, Stock RG, Cesaretti JA, et al (2008). Association of single nucleotide polymorphisms in SOD2, XRCC1 and XRCC3 with susceptibility for the development of adverse effects resulting from radiotherapy for prostate cancer. Radiat Res, 170, 49-59.
10. Butkiewicz D, Rusin M, Enewold L, et al (2001). Shields PG, Chorazy M, Harris CC. Genetic polymorphisms in DNA repair genes and risk of lung cancer. Carcinogenesis, 22, 593-7.
11. Chang-Claude J, Popanda O, Tan XL, et al (2005). Association between polymorphisms in the DNA repair genes, XRCC1, APE1, and XPD and acute side effects of radiotherapy in breast cancer patients. Clin Cancer Res, 11, 4802-9.
12. Chang-Claude J, Ambrosone CB, Lilla C, et al (2009). Genetic polymorphisms in DNA repair and damage response genes and late normal tissue complications of radiotherapy for breast cancer. Br J Cancer, 100, 1680-6.
13. Collett D (2003). Modelling survival data in medical research. U.S.A.:Chapman & Hall/CRC Boca Raton, FL, USA.
14. Damaraju S, Murray D, Dufour J, et al (2006). Association of DNA repair and steroid metabolism gene polymorphisms with clinical late toxicity in patients treated with conformal radiotherapy for prostate cancer. Clin Cancer Res, 12, 2545-54.
15. Damaraju S, Murray D, Dufour J, et al (2006). Association of DNA repair and steroid metabolism gene polymorphisms with clinical late toxicity in patients treated with conformal radiotherapy for prostate cancer. Clin Cancer Res, 12, 2545-54.
16. de Boer J, Hoeijmakers JH (2000). Nucleotide excision repair and human syndromes. Carcinogenesis, 21, 453-60.
17. Falvo E, Strigari L, Citro G, et al (2011). Dose and polymorphic genes xrcc1, xrcc3, gst play a role in the risk of article developing erythema in breast cancer patients following single shot partial breast irradiation after conservative surgery. BMC Cancer, 11, 291.
18. Falvo E, Strigari L, Citro G, et al (2012). SNPs in DNA repair or oxidative stress genes and late subcutaneous fibrosis in patients following single shot partial breast irradiation. J Exp Clin Cancer Res, 31, 7.
19. Fisher B, Anderson S, Bryant J, et al (2002). Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med, 347, 1233-41.
20. Funke S, Brenner H, Chang-Claude J (2008). Pharmacogenetics in colorectal cancer: a systematic review. Pharmacogenomics, 9, 1079-99.
21. Giotopoulos G, Symonds RP, Foweraker K, et al (2007). The late radiotherapy normal tissue injury phenotypes of telangiectasia, fibrosis and atrophy in breast cancer patients have distinct genotype-dependent causes. Br J Cancer, 96, 1001-7.
22. Hao B, Miao X, Li Y, et al (2006). A novel T-77C polymorphism in DNA repair gene XRCC1 contributes to diminished promoter activity and increased risk of non-small cell lung cancer. Oncogene, 25, 3613-20.
23. Heijmakers JH (2001). Genome maintenance mechanisms for preventing cancer. Nature, 411, 366-74.
24. Héry C, Ferlay J, Boniol M, Autier P (2008). Changes in breast cancer incidence and mortality in middle-aged and elderly women in 28 countries with Caucasian majority populations. Ann Oncol, 19, 1009-18.
25. Lunn RM, Langlois RG, Hsieh LL, Thompson CL, Bell DA (1999). XRCC1 polymorphisms: effects on aflatoxin B1-DNA adducts and glycophorin A variant frequency. Cancer Res, 59, 2557-61.
26. Mangoni M, Bisanzi S, Carozzi F, et al (2011). Association between genetic polymorphisms in the XRCC1, XRCC3, XPD, GSTM1, GSTT1, MSH2, MLH1, MSH3, and MGMT genes and radiosensitivity in breast cancer patients. Int J Radiat Oncol Biol Phys, 81, 52-8.
27. Minelli C, Thompson JR, Abrams KR, Thakkinstian A, Attia J (2005). The choice of a genetic model in the meta-analysis of molecular association studies. Int J Epidemiol, 34, 1319-28.
28. Moullan N, Cox DG, Angele S, et al (2003).Romestaing P, Gerard JP, Hall J. Polymorphisms in the DNA repair gene XRCC1, breast cancer risk, and response to radiotherapy. Cancer Epidemiol Biomarkers Prev, 12, 1168-74.
29. Raabe A, Derda K, Reuther S, et al (2012). Association of single nucleotide polymorphisms in the genes ATM, GSTP1, SOD2, TGFB1, XPD and XRCC1 with risk of severe erythema after breast conserving radiotherapy. Radiat Oncol, 7, 65 .
30. Safwat A, Bentzen SM, Turesson I, Hendry JH (2002). Deterministic rather than stochastic factors explain most of the variation in the expression of skin telangiectasia after radiotherapy. Int J Radiat Oncol Biol Phys, 52, 198-204.
31. Schnur JB, Ouellette SC, Dilorenzo TA, Green S, Montgomery GH (2011). A qualitative analysis of acute skin toxicity among breast cancer radiotherapy patients. Psychooncology, 20, 260-8.
32. Shen MR, Jones IM, Mohrenweiser H (1998). Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res, 58, 604-8.
33. Stern MC, Umbach DM, van Gils CH, Lunn RM, Taylor JA (2001). DNA repair gene XRCC1 polymorphisms, smoking, and bladder cancer risk. Cancer Epidemiol Biomarkers Prev, 10, 125-31.
34. Terrazzino S, La Mattina P, Masini L, et al (2012). Common variants of eNOS and XRCC1 genes may predict acute skin toxicity in breast cancer patients receiving radiotherapy after breast conserving surgery. Radiother Oncol, 103, 199-205 .
35. Thakkinstian A, McEvoy M, Minelli C, et al (2005). Systematic review and meta-analysis of the association between {beta} 2-adrenoceptor polymorphisms and asthma: a HuGE review. Am J Epidemiol, 162, 201-11.
36. Vidal AE, Boiteux S, Hickson ID, Radicella JP (2001). XRCC1 coordinates the initial and late stages of DNA abasic site repair through protein-protein interactions. EMBO J, 20, 6530-9.
37. Wang Y, Zhang D, Zheng W, et al (2008). Multiple gene methylation of nonsmall cell lung cancers evaluated with 3-dimensional microarray. Cancer, 112, 1325-36.
38. Wan Y, Wang Y, Luo J, Lu Z (2007). Bisulfite modification of immobilized DNAs for methylation detection. Biosens Bioelectron, 22, 2415-21.
39. Xiao PF, Cheng L, Wan Y, et al (2006). An improved gel-based DNA microarray method for detecting single nucleotide mismatch. Electrophoresis, 27, 3904-15.
40. Xiao P, Huang H, Zhou G, Lu Z (2007). Gel immobilization of acrylamide-modified single-stranded DNA template for pyrosequencing. Electrophoresis, 28, 1903-12.
41. Zhang X, Miao X, Liang G, et al (2005). Polymorphisms in DNA base excision repair genes ADPRT and XRCC1 and risk of lung cancer. Cancer Res, 65, 722-6.
42. Zhou L, Xia J, Li H, Dai J, Hu Y (2010). Association of XRCC1 variants with acute skin reaction after radiotherapy in breast cancer patients. Cancer Biother Radiopharm, 25, 681-5.
43. Zintzaras E, Lau J (2008). Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches. J Clin Epidemiol, 61, 634-45.
44. Zschenker O, Raabe A, Boeckelmann IK, et al (2010). Association of single nucleotide polymorphisms in ATM, GSTP1, SOD2, TGFB1, XPD and XRCC1 with clinical and cellular radiosensitivity. Radiother Oncol, 97, 26-32.